Ezrin, a widespread protein involved in cell migration, morphogenesis and cell adhesion, belongs to a large family of proteins known as ERM (ezrin, radixin, moesin). These three closely related proteins are thought to function as linkers between plasma membrane and actin cytoskeleton and their function is regulated by the small GTP-binding protein Rho. It has been previously shown that the active form of radixin can bind in vitro to Dbl, a Rho-specific guanine nucleotide exchange factor, although an in vivo interaction has not yet been demonstrated. In this paper, we attempted to investigate whether ezrin can also associate with Dbl. We show here that Dbl protein can effectively bind both in vitro and in vivo to the N-terminal region (amino acids 1-531) of a constitutively active mutant of ezrin and with the full-length molecule. We found that this binding is mediated by the Dbl pleckstrin homology domain, responsible for the proper subcellular localization of the Dbl protein. Moreover, we show that Dbl induces localization to the plasma membrane of both the active deletion mutant and the full-length ezrin proteins. Finally, we show that the relocalization of ezrin is independent of Dbl GEF activity. These results indicate that Dbl could induce translocation of ezrin to the plasma membrane through a mechanism that does not require ezrin C-terminus phosphorylation by Rho-associated kinases.
Introduction
The Dbl oncogene is the prototype of a large family of proteins all characterized by a region of homology sequences in which a Dbl homology domain (DH), responsible for catalysing the nucleotide exchange on Rho GTPases, is located immediately N-terminal to the pleckstrin homology domain (PH), responsible for proper subcellular localization of the protein (Katan and Allen, 1999; Razzini et al. , 2000; Zheng, 2001) . The guanine nucleotide exchange activity of Dbl protein promotes the conversion of Rho small GTPases from the GDP-bound inactive state to the GTP-bound active form. The small GTP-binding proteins constitute a large family of signaling molecules that regulate several biological processes, including actin cytoskeleton reorganization, cell motility, intracellular trafficking, cell growth and development (Van Aelst and D'SouzaSchorey, 1997; Hall et al., 1998) . Moreover, the GTPase Rho regulates the activation of ERM proteins and their association with the plasma membrane (Hirao et al., 1996) . The ERM family consists of three closely related proteins (ezrin, radixin and moesin) that are thought to work as crosslinkers between plasma membrane and actin-based cytoskeleton (Mangeat et al., 1999) . Each ERM protein contains a highly conserved N-terminal domain, N-ERMAD (ERM association domain), involved in the interaction with transmembrane proteins, and a C-terminal F-actin-binding domain, C-ERMAD (Algrain et al., 1993) . Both the actin-and membranebinding domains seem to be masked in native full-length ERM proteins, suggesting an intramolecular and/or intermolecular association that mutually suppresses their functions (Turunen et al., 1994; Gary and Bretscher, 1995) . The activation of ERM proteins leads to the disruption of the intramolecular association allowing the stabilization of the open conformation (Matsui et al., 1998) and thus the N-terminal and Cterminal regions to interact with their respective binding partners. Two distinct signals have been proposed as effectors of ERM protein activation: the phosphorylation, by Rho-dependent kinase ROCK, of a conserved C-terminal threonine residue, localized in a consensus COOH-terminal region of ERM proteins (Nakamura et al., 1996; Matsui et al., 1998; Oshiro et al., 1998; Hayashi et al, 1999) , and the binding of phosphatidylinositol-4,5-biphosphate (Niggli et al., 1995; Hirao et al., 1996; Barret et al., 2000) , produced by the activity of phopshatidylinositol 4-phosphate 5-kinase (PI4P5K) Nakamura et al., 1999) , which in turn is stimulated by Rho and activated ROCK (Oude Weernink et al., 2000) . Thus Rho, upon activation by guanine nucleotide exchange factors (GEFs), may act as an upstream activator of ERM. An opposite scenario indicates ERM proteins acting upstream of Rho by binding to and inhibiting Rho-specific GDP dissociation inhibitor (GDI) (Takahashi et al., 1997) , allowing activation of Rho by its specific Rho GEF.
It has been shown that one of the ERM proteins, radixin, can associate with Rho GEF Dbl, although this interaction has not been demonstrated to occur in vivo (Takahashi et al., 1998) . More recently, Tran Quang et al. (2000) have reported a functional dependence of Rho GEF Dbl and Net on ezrin, and showed that ROCK-dependent phosphorylation of ezrin C-ERMAD is required for both RhoA and RhoGEFinduced ezrin relocalization, although a direct interaction between ERM and Rho GEFs has not been shown. Nevertheless, the requirement of ezrin function for ROCK-mediated fibroblasts transformation by GEFs suggests that ERM proteins may act as upstream activators of Rho not only through their association with Rho GDI but also through their interaction with Rho GEFs.
In light of these studies, we attempted to determine whether Dbl product can interact with ezrin and whether this interaction can occur in vivo. We report here that Dbl can efficiently associate both in vitro and in vivo with a constitutively active mutant of ezrin, lacking the C-terminus last 60 amino acids, including the actin-binding site. We found that the binding of Dbl with ezrin is specifically mediated by the PH domain and that mutations inhibiting the binding to phospholipids do not affect this interaction. Moreover, we show that Dbl protein can induce the translocation to the membrane of both the full-length ezrin protein and the mutant ezrin protein lacking the C-ERMAD domain, including the phosphorilable threonine. Finally, we show that the relocalization of ezrin to the plasma membrane is independent of Dbl GEF activity. These results imply that phosphorylation of ezrin C-ERMAD by Rho-dependent kinases is not indispensable for Dbl-induced membrane localization of ezrin.
Results

In vitro binding of Dbl oncoprotein with ezrin
We analysed the ability of Dbl protein to interact in vitro with ezrin. We used a GST-tagged ezrin full-length (f.l.) and a GST-tagged truncated form (DC) of ezrin, in which the last C-terminal region, spanning 60 aminoacids residues, and containing the phosphorylable threonine, had been deleted. COS-7 cell lysates expressing Dbl protein were incubated with glutathionesepharose-immobilized, GST-fused, full-length and truncated forms of ezrin. After extensive washing, the retained proteins were subjected to anti-Dbl Western blotting. As shown in Figure 1a , both ezrin f.l. and ezrin DC were able to bind efficiently to Dbl oncoprotein, whereas the GST control did not. When the pEF-1B ezrin f.l. and pEF-1B ezrin DC were expressed in COS-7 cells and subjected to a pull-down assay with the immobilized GST-Dbl, we found that Dbl was able to bind tightly to pEF-1B ezrin f.l. and pEF-1B ezrin DC in the glutathione-sepharose coprecipitates under conditions in which GST alone did not interact with either forms of ezrin (Figure 1b) . Moreover, the results shown indicate that Dbl protein in vitro associates more efficiently with the constitutively active mutant of ezrin (DC) but more weakly with the inactive (f.l.) molecule.
Dbl PH domain directly interacts with N-terminal region of ezrin
To identify the specific domain of Dbl responsible for the interaction of the protein with the ERM proteins all Dbl subdomains, DH, PH and C-terminal sequences, were employed as GST-tagged probes. As shown in Figure 2 , the binding of Dbl protein with ezrin occurs through the PH domain. In fact, the Dbl DH and Cterminal domains do not interact with ezrin f.l. or with ezrin DC (Figure 2) . Mutations of basic residues in the b1 region of PH domain of several proteins have been shown to affect protein intracellular localization. While some of these amino acids are involved in the direct interaction with phosphoinositides (PIPs), others were shown to bind F-actin. To delineate the region of amino acids in the PH domain that may be involved in the interaction with ezrin, three Dbl mutant proteins, containing substitutions of basic amino acids in the PH domain, were employed as GST-tagged probes. The first mutant, (DH/PH-t), containing a triple substitution of Lys 712 to Ala, Lys 714 to Ala, and Arg 724 to Gly, unable to bind to PIPs and to localize to the plasma membrane has been previously described (Russo et al., 2001 GST-ezrin full-length (f.l.) and GST-truncated ezrin (DC) were produced in E. coli and purified by affinity chromatography. Purified proteins were immobilized onto glutathione-sepharose beads and incubated with lysate from COS-7 cell expressing Dbl. The bound fractions were subjected to SDS-PAGE, followed by immunoblotting with anti-Dbl antibody. (b) COS-7 cells were transfected with pCEFL-GST, pCEFL-GST-Dbl, pEF-1B ezrin and pEF-1B ezrin DC. GST and GST-Dbl proteins were immobilized onto glutathione-sepharose beads. Beads were washed and incubated with lysates from cell expressing Xpress-ezrin (1) and Xpress-ezrin DC (2). The bound fractions were subjected to SDS-PAGE, followed by immunoblotting with anti-Xpress antibody. The amount of GST and GST-Dbl in total lysates was determined by Western blotting with anti-GST specific antibody.
Results are representative of three independent experiments
In vivo association of ezrin with (Vanni et al., unpublished observations) . Figure 3 shows that all three DH/ PH mutants maintain their capability of binding to ezrin. These results imply that the region of the PH domain comprised between b1 and b2 sheets is not involved in the association with ezrin N-terminal domain.
Dbl oncoprotein interacts in vivo with ezrin
In vitro data clearly demonstrated the binding of Dbl protein with both f.l. and C-terminal-deleted ezrin. To determine whether the association between Dbl and ezrin could occur in vivo, GST-Dbl was coexpressed with Xpress-tagged ezrin f.l. and ezrin DC in COS-7 cells, and the coimmunoprecipitation pattern of GST-Dbl with the Xpress-tagged proteins was determined. Both ezrin f.l. and ezrin DC formed a stable complex with Dbl protein as revealed by the anti-Xpress Western blot of the anti-Dbl immunoprecipitates ( Figure 4a ). The reciprocal experiment was also performed. In this case as well, stable complexes between Dbl and ezrin could be detected, as shown by the anti-Dbl Western blot of the anti-Xpress immunoprecipitates ( Figure 4b ). The results shown in Figure 4a and b reveal that Dbl associates in vivo Figure 3 Mutations in the Dbl PH or DH domain do not alter the binding ability of the oncogene. (a) COS 7 cells were transfected with pCefl-GST, pCefl-GST-Dbl, pCefl-GST-PH, pCefl-GST-PH-t, pCefl-GST-DH/PH AL, , pCefl-GST-DH/PH LL, , pCefl-GST-pMA17, pEF-1B ezrin and pEF-1B ezrin DC. GST, GST-Dbl, GST-PH, GST-PH-t, GST-DH/PH AL , GST-DH/PH LL and GST-pMA17 proteins were independently immobilized onto glutathione-sepharose beads. Beads were washed three times and incubated with lysates from COS-7 cells expressing Xpress-ezrin (1) and Xpress-ezrin DC (2). The bound fractions were subjected to SDS-PAGE, followed by immunoblotting with anti-Xpress antibody. Results shown are representative of three independent experiments. (b) To control for protein expression level, 100 mg from each cell lysate of Figure 3a was subjected to SDS-PAGE, followed by immunoblotting with anti-GST or anti-Xpress antibody, as indicated Figure 2 Dbl interaction with ezrin is mediated by the PH domain. COS-7 cells were transfected with pCEFL-GST, pCEFL-GST-Dbl, pCEFL-GST-PH, pCEFL-GST-DH, pCEFL-GST-Cter, pEF-1B ezrin and pEF-1B ezrin DC. GST, GST-Dbl, GST-PH, GST-DH and GST-C-ter proteins were independently immobilized onto glutathione-sepharose bead. Beads were washed three times and then incubated with lysates from cells expressing Xpress-ezrin (1) and Xpress-ezrin DC (2). The sepharose bead coprecipitates were detected by anti-Xpress immunoblotting. The amount of GST-tagged proteins in total lysates was determined by Western blotting with anti-GST-specific antibody. Results shown are representative of three independent experiments
In vivo association of ezrin with Dbl protein C Vanni et al with both ezrin f.l. and ezrin DC. We then investigated if Dbl oncoprotein could interact with endogenous ezrin. We transiently transfected NIH3T3 cells with GST-Dbl and the coimmunoprecipitation pattern of GST-Dbl with the endogenous ezrin protein was determined. As shown in Figure 4c , endogenous ezrin formed a stable complex with Dbl protein as revealed by the anti-Dbl Western blot of the anti-ezrin immunoprecipitates. When the reciprocal experiment was performed, the complex between Dbl and endogenous ezrin could be detected as well (Figure 4c ). In summary, these results indicate that Dbl and ezrin can efficiently interact in vivo.
Relocalization of ezrin to the plasma membrane in the presence of Dbl oncoprotein
We used transient transfection assay to evaluate the ability of Dbl protein to induce relocalization of both ezrin f.l. and ezrin DC. NIH3T3 fibroblasts expressing the ezrin f.l. alone showed an elongated and fibroblastic shape, with actin cytoskeleton organized in thin long stress fibers disposed along the major axis of the cell, as previously reported (Tran Quang et al., 2000) . The staining of ezrin f.l. was cytoplasmic, with no membrane localization (Figure 5a ), and no distribution of ezrin along the filamentous actin was observed (Figure 5a merge) . When expressed alone, ezrin DC mutant exhibited a diffuse cytoplasmic staining similar to that of ezrin f.l. (Figure 5a) . To investigate the possible relocalization of the f.l. or the mutated form of ezrin in the presence of Dbl oncoprotein, we performed a triple immunofluorescence of NIH3T3 fibroblasts co-expressing onco-Dbl and ezrin f.l. or onco-Dbl and ezrin DC. As previously reported (Vanni et al., 2002) , NIH3T3 fibroblasts expressing the onco-Dbl alone showed a typical Dbl-transformed phenotype, characterized by an enlarged and polygonal shape, and by the actin cytoskeleton organized in prominent stress fibers, sparse ruffling, and occasional lamellipodia at the cell surface ( Figure 5a ). The immunofluorescence staining of Dbl protein appeared, as expected (Vanni et al., 2002) , diffuse in the cytoplasm (Figure 5a ), where it colocalized with actin stress fibers, and distributed on the cell plasma membrane (Figure 5a ), where it colocalized with the phalloidin signal corresponding to the polymerized actin cortical cytoskeleton (Figure 5a ). In cells co-expressing Dbl and ezrin f.l. or ezrin DC proteins, staining for ezrin appeared localized to the cell plasma membrane, where costaining with Dbl protein on ruffles or lamellipodia could be observed (Figure 5b , arrows). Similar results were obtained when cells co-expressing DH/PH AL or DH/PH LL mutants and ezrin f.l. or ezrin DC proteins were analysed. Ezrin appeared localized to the cell plasma membrane, where costaining with Dbl protein could be observed (Figure 5b) .
It has been reported that coexpression of Dbl and ezrin f.l. induces an increase in the number of focal adhesions (Tran Quang et al., 2000) . Therefore, to analyse the effect of coexpression of Dbl and ezrin f.l and ezrin DC on the number and distribution of focal adhesions, we performed double immunofluorescence with anti-paxillin antibodies in NIH3T3 fibroblasts coexpressing onco-Dbl and ezrin f.l. or onco-Dbl and ezrin DC. In cells coexpressing Dbl and ezrin f.l., staining of paxillin revealed abundant focal adhesions, which appeared distributed all over the ventral region of the cells (Figure 5c ). In contrast, in cells coexpressing Dbl and ezrin DC, focal adhesions appeared less numerous compared with cells coexpressing Dbl and ezrin f.l. (Figure 5c ). Thus, Dbl expression induces a relocalization of both the f.l. and the mutated forms of ezrin. Moreover, Figure 4 Dbl interacts in vivo with ezrin. Xpress-ezrin and Xpressezrin DC were coexpressed in COS-7 cells with GST and GST-Dbl. Cell lysates were subjected to anti-Dbl or anti-Xpress immunoprecipitation followed by anti-Xpress (a) or anti-Dbl (b) Western blotting. (c) COS-7 cells were transfected with GST and GST-Dbl. Cell lysates were subjected to anti-Dbl or anti-ezrin immunoprecipitation followed by anti-Dbl or anti-ezrin Western blotting.
Results shown are representative of three independent experiments
In vivo association of ezrin with Dbl protein C Vanni et al coexpression of Dbl and ezrin f.l. resulted in enhanced focal adhesion assembly, while expression of ezrin DC partly inhibited focal adhesion formation induced by Dbl expression.
Relocalization of ezrin to the plasma membrane is independent of Dbl GEF activity
To determine whether the relocalization of ezrin to the plasma membrane reflects its interaction with Dbl or
In vivo association of ezrin with Dbl protein C Vanni et al results from the activation of Rho GTPases by the oncoprotein, we used a Dbl mutant that carries a deletion (residues 664-670) in the DH domain, pMA17, previously shown to be unable to induce cellular transformation and to activate GTPases (Ron et al., 1991; Hart et al., 1994) . As shown in Figure 3a , both ezrin f.l. and ezrin DC were able to bind efficiently to GST-tagged pMA17. We thus examined the ability of pMA17 to induce translocation of ezrin in vivo. As shown in Figure 5d , the deletion in the DH domain does not affect the intracellular localization of the mutated Dbl protein and its expression induces the translocation of both ezrin f.l. and ezrin DC to the plasma membrane. (Figure 5d ). These results indicate that the Dbl GEF activity is not necessary for the relocalization of ezrin to the plasma membrane. Conversely, when we used the DH/PH-t mutant, unable to bind to PIPs and to localize to the plasma membrane, ezrin f.l. and ezrin DC proteins remained cytoplasmic and no localization to the plasma membrane could be detected (Figure 5d , arrowheads).
To investigate the possible relocalization of the f.l. or mutated form of ezrin in the presence of the PH domain alone, we performed a triple immunofluorescence of NIH3T3 fibroblasts coexpressing wt PH and ezrin f.l. or ezrin DC. The immunofluorescence staining for ezrin f.l or ezrin DC appeared localized to the cell plasma membrane, where costaining with Dbl PH domain could be observed (Figure 5d ). Conversely, when NIH3T3 cells were transiently cotransfected with a PH domain mutant, unable to bind to PIPs and to localize to the plasma membrane (Russo et al., 2001) , ezrin f.l. (Figure 5d ) and ezrin DC (not shown) remained cytoplasmic.
Discussion
It has been previously shown that Dbl protein interacts in vitro with radixin (Takahashi et al. , 1998) , suggesting that Dbl GEF activity may be modulated by ERM, although an in vivo interaction has not been found. Here we provide evidence that Dbl interacts with ezrin both in vitro in a cell-free assay and in the cells, where Dbl can interact with both the exogenous as well as the endogenous ezrin protein. This interaction also occurs when a deletion mutant of ezrin is used. In this mutant, the lack of the C-ERMAD sequences produces a protein that is unable to fold such that the N-terminal and the C-terminal region mutually mask each other, but that is available for free association with its effectors through its N-ERMAD region. In fact, we show here that the mutant protein in vitro associates more efficiently with Dbl than its wild-type counterpart. The stronger binding to Dbl of the mutant protein is probably due to the exposure of the N-ERMAD domain, which can freely interact with the Dbl protein.
Next, we present here evidence that ezrin associates with Dbl PH domain. DH domain and C-terminal domain were in fact inefficient in binding to ezrin. PH domain mutants, unable to associate with PIPs or with actin cytoskeleton, retain the ability to associate with ezrin, indicating that different amino acids in the PH domain have distinct specificity for defined substrates and that the PH region between b1 and b2 sheets is not responsible for Dbl binding to ezrin.
We show here that both Dbl and ezrin localize to the plasma membrane when they are coexpressed in NIH3T3 cells and that this occurs with both the wildtype and the mutant forms of ezrin protein. The lack of the C-terminal region apparently does not influence the ability of ezrin to localize to the plasma membrane, but its relocalization seems to be dependent on Dbl expression, since ezrin DC alone localizes to the cytosol.
The abundance of focal adhesion we observed in cells coexpressing Dbl and ezrin f.l. is in agreement with previously published results (Tran Quang et al., 2000) . The reduced assembly of focal adhesion and stress fibers in cells cotransfected with Dbl and ezrin DC can be explained by the lack of the actin binding C-ERMAD domain. On the other hand, comparison between cells expressing onco-Dbl alone and cells co-expressing onco-Dbl and ezrin DC indicates that inhibition of focal adhesion by mutated ezrin does not affect the morphology of the transformed cells (Figure 5c ). Thus, while a Thr 567 mutant inhibits Dbl-induced cell morphological transformation (Tran Quang et al., 2000) , the ezrin DC does not and interference with proper cytoskeleton organization is probably partly overcome in Dbl-transformed cells by the onco-protein activity. Figure 5 Immunofluorescence analysis of the distribution of GST-Dbl and Xpress-ezrin fusion proteins. (a) NIH3T3 cells transfected with pCEFL-GST-Dbl, pEF-1B ezrin f.l. or pEF-1B ezrin DC were double immunolabeled with TRITC-phalloidin as described in Materials and methods. Staining of Dbl (green) appears mostly diffused in the cytoplasm of the cells and localized to the plasma membrane. The actin (red) is organized in well-evident short stress fibers and some ruffling and lamellipodia. Labeling of ezrin (blue), either f.l. or DC, is cytoplasmic, with no cell membrane localization. The actin (red) is organized in long thin stress fibers in cells expressing either f.l. or DC ezrin. Bar, 10 mm. (b) NIH3T3 fibroblasts were cotransfected with pCEFL-GST-Dbl, pCEFL-GST-DH/ PH AL , pCEFL-GST-DH/PH LL and pEF-1B ezrin f.l. or pEF-1B ezrin DC, and analysed by triple labeling for Dbl (green), ezrin (blue) and F-actin (red), as described in Materials and methods. In cotransfected cells, Dbl induces the translocation of ezrin, either f.l. or DC, from the cytoplasm to the plasma membrane (arrows), where it colocalizes with Dbl (merge). Bar, 10 mm. (c) NIH3T3 fibroblasts were stably cotransfected with pCEFL-GST-Dbl and pEF-4B ezrin f.l. or pCEFL-GST-Dbl and pEF-4B ezrin DC, as indicated. Cells were fixed, permeabilized and stained for Dbl (green) and paxillin (red), as described in materials and methods. Ezrin expression was confirmed by anti-His staining (data not shown). In cells cotransfected with pCEFL-GST-Dbl and pEF-4B ezrin f.l., focal adhesions appear increased compared to cells cotransfected with pCEFL-GST-Dbl and pEF-4B ezrin DC. Bar, 10 mm. (d) NIH3T3 fibroblasts were transfected with pCEFL-GST-pMA17, pCEFL-GST-DH/PH-t, pCEFL-GST-PH wt and pCEFL-GST-PH-t together with pEF-1B ezrin f.l. or pEF-1B ezrin DC, as indicated, and analysed by triple labeling for Dbl (green), ezrin (blue) and F-actin (red), as described in Materials and methods. In cotransfected cells, Dbl mutant pMA17 and PH wt induce the translocation of ezrin, either f.l. or DC, from the cytoplasm to the plasma membrane (arrows), where colocalization with Dbl (merge) can be observed. On the contrary, pCEFL-GST-DH/PH-t and pCEFL-GST-PH-t do not localize to the plasma membrane and do not induce the relocalization of ezrin, either f.l. or DC (arrowheads). Bar, 10 mm.
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Finally, we show here that Dbl GEF activity is not indispensable for the relocalization of ezrin or ezrin DC. Not only a GEF activity defective Dbl mutant induces translocation of ezrin to the plasma membrane but so does the PH domain alone. Conversely, Dbl and PH domain mutants that retain the ability to interact with ezrin in vitro but that are unable to localize to the plasma membrane do not affect ezrin proteins subcellular localization.
Ezrin exists in unstimulated cells as a soluble cytosolyc protein that relocalizes in response to a variety of stimuli. These stimuli may induce the phosphorylation of the threonine residue in the C-ERMAD region causing the unfolding of the protein and its interaction with polymerized actin and the plasma membrane. The mechanisms of ERM proteins activation remain partly unclear and controversial. Phosphatidylinositol 4,5-biphosphate (PI4,5P 2 ) has been reported to bind to ERM proteins, inducing their activation and the consequent relocalization and binding to the plasma membrane and the actin filaments (Niggli et al., 1995; Hirao et al., 1996; Heiska et al., 1998; Huang et al., 1999; Nakamura et al., 1999; Niggli, 2001; Yonemura et al., 2002) . In fact, the crystal structure analysis of radixin has revealed a basic cleft, located in the N-ERMAD region of the protein, which can bind the headgroup of PI4,5P 2 (Hamada et al., 2000) . Moreover, it was shown that mutagenesis of the PI4,5P 2 putative binding site in the N-terminal domain of ezrin alters its membrane localization, suggesting that PI4,5P 2 is important in ERM protein function (Barret et al., 2000) .
The small GTPase Rho, which induces actin stress fibers formation (Hall, 1998) , is thought to be involved in ERM proteins activation as well. Evidences indicate that ERM proteins translocation to the plasma membrane and accumulation in microvilli is dependent on Rho activation (Hirao et al., 1996; Shaw et al., 1998; Matsui et al., 1998 Matsui et al., , 1999 . Moreover, the Rho-dependent kinase ROCK can induce the phosphorylation of ERM in the C-ERMAD in vitro and in vivo (Matsui et al., 1998; Oshiro et al., 1998) , inducing the relocalization of ezrin to the dorsal actin-containing cell surface protrusions (Tran Quan et al., 2000) . Similarly, constitutively activated Rho and Dbl induce ezrin relocalization. In the same study, Tran Quang and co-workers have investigated the connection between RhoA, ezrin, and Dbl-induced transformation, showing that ezrin function is required for ROCK-mediated fibroblast transformation by the Dbl protein. They have also shown that mutagenesis of T567 residue, conserved among ezrin, radixin and moesin, blocks activated RhoA, ROCK and Dbl-induced relocalization of ezrin to the plasma membrane.
Our data indicate that the lack of the C-ERMAD region, and thus the lack of the phosphorylable threonine, does not affect Dbl-induced localization of ezrin to the plasma membrane. These results imply that Thr567 phosphorylation by activated ROCK is not necessary for this event. At this stage, it is not clear how Dbl influences ezrin translocation to the plasma membrane. The interaction between ezrin and Dbl may occur without GEF activity between the PH domain and the unfolded ezrin protein molecules present in the cell. Translocation of Dbl and ezrin to the plasma membrane may then allow Dbl to interact with its substrates. It is possible that the activation by Dbl of Rho GTPases, such as RhoA and Rac, may induce activation of PI4P5K and synthesis of PI4,5P 2 , which may then be responsible for the translocation of more ezrin to the plasma membrane. In agreement with previous studies, Rho-dependent phosphorylation of the C-terminal threonine may be relevant for the unfolding of the protein and its stabilization, while Rho-dependent accumulation of PI4,5P 2 may be necessary for Dblinduced ezrin activation. Although more work will be needed to define the exact interplay between Dbl and ezrin or whether other Rho GEFs may interact with ERM proteins, one possibility consistent with these data is that the two proteins function cooperatively to detect specific membrane proteins and phosphoinositides.
Materials and methods
Plasmids and constructs
pCEFL-GST-Dbl, pCEFL-GST-DH/PH-t, pCEFL-GST-PH, pCEFL-GST-PH-t, pCEFL-GST-NP, pCEFL-GST-DH and pCEFL-wt constructs were previously described (Russo et al. , 2001; Vanni et al., 2002) . pCEFL-GST DH/PH AL and pCEFL-GST-DH/PH LL were prepared by mutagenesis as previously described (Russo et al., 2001; Vanni et al., 2002) . Plasmid expressing human ezrin (pCB6) was kindly provided by Dr M Arpin. The coding region of Dbl mutant pMA17 (Ron et al., 1991) was subcloned into the BamHI site of pCEFL-GST vector and the coding region of human ezrin was subcloned into the XbaI site of pEF-1B vector (Invitrogen). The truncated form of ezrin (pEF-1B ezrin DC), which lacks the last C-terminal 60 amino acids, was generated by polymerase chain reaction (PCR) of 1.6 kbp fragment from the ATG of the coding sequence (starting at nucleotide 121) to the Cell II restriction site (nucleotide 1717). After subcloning into the XbaI site of pEF-1B vector, the PCR product was sequenceproofed by the T7 Sequenase version 2.0 kit (Amersham). For stable double transfected cell lines, ezrin f.l. and ezrin DC were subcloned into pEF-4 vector (Invitrogen). For ezrin proteins production in Escherichia coli and purification, the f.l. and the truncated form of ezrin cDNAs were transferred into the pGEX-KG vector (Amersham Pharmacia Biotech). GST fusion proteins were expressed and purified using glutathione-sepharose beads as described (Smith and Johnson, 1988) .
Cell culture and transfection
COS-7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum. For binding assay, cells were grown to 80% confluency in 100 mm tissue culture dishes and transiently transfected with 4 mg of the indicated plasmids using lipofectAMINE PLUS as described by the manufacturer (Invitrogen). At 20 h before lysis, the medium was changed to 10% fetal calf serum. NIH3T3 cells were stably cotransfected with the different pCEFL-GST-Dbl constructs and pEF-4B ezrin f.l. or pEF-4B ezrin DC by the calcium phosphate coprecipitation method and cultured in DMEM supplemented with 10% calf serum, 375 mg/ml G418 and 350 mg/ml zeocin (Invitrogen). Alternatively, NIH3T3 cells were transiently transfected with 4 mg of the indicated plasmids using lipofectAMINE PLUS and collected 36 h later.
In vitro binding assay for interaction of GST-ezrin and Dbl
To evaluate the binding of Dbl with ezrin, 300 mg of bacterial lysate of GST f.l. and truncated form of ezrin were incubated on 60 ml of glutathione-coupled sepharose beads (Amersham Pharmacia Biotech) for 1 h at 41C under constant rotation. After brief centrifugation, beads were washed three times with one volume of lysis buffer containing 20 mM Tris HCl pH 7.5, 0.1% Triton X-100, 10% glycerol, 1 mM AEBSF, 20 mg/ml each leupeptin and aprotinin. The beads were then incubated with 800 mg of clarified lysate from COS-7 cells transfected with the indicated pCEFL-GST-Dbl constructs for 1 h and 30 min at 41C. The beads were then washed four times with 500 ml of lysis buffer, eluted in 40 ml of 1X Laemmli's buffer and subjected to 8% SDS-PAGE. Bound Dbl was detected in Western Blot using polyclonal antibody anti-Dbl (Zangrilli and Eva, 1995) .
In vitro binding assay for interaction of GST-Dbl and Xpressezrin
Lysates (800 mg) from COS-7 cells transfected with pCEFL-GST, pCEFL-GST-Dbl, pCEFL-GST-pMA17, pCEFL-GST-PH, pCEFL-GST-PH-t, pCEFL-GST-DH, pCEFL-GST-DH/ PH AL and pCEFL-GST-DH/PH LL were incubated on glutathione-coupled sepharose beads (Amersham Pharmacia Biotech) for 1 h at 41C under constant rotation. After brief centrifugation, beads were washed three times with 500 ml of lysis buffer containing 20 mM Tris HCl pH 7.5, 0.1% Triton X-100, 10% glycerol, 1 mM AEBSF, 20 mg/ml each leupeptin and aprotinin. The beads were then incubated with 800 mg of lysates from COS-7 cells transfected with pEF-1B ezrin f.l. and pEF-1B ezrin DC for 1 h and 30 min at 41C. The beads were washed four times with 500 ml of lysis buffer, eluted in 40 ml of 1 Â Laemmli's buffer and subjected to 8% SDS-PAGE. Bound ezrin was detected by immunoblotting with a monoclonal antibody specific for the Xpress tag (Invitrogen).
Coimmunoprecipitation COS-7 cells were transfected with plasmids encoding for pCEFL-GST or pCEFL-GST-Dbl alone or cotransfected with pEF-1B ezrin f.l. or pEF1B-ezrin DC. Cells were washed with ice-cold phosphate-buffered saline and lysed with a buffer containing 20 mM Tris HCl pH 7.5, 0.1%Triton X-100, 10% glycerol, 1 mM AEBSF, 20 mg/ml each leupeptin and aprotinin.
Lysates were clarified by centrifugation and equivalent amounts of cellular proteins were incubated for 1 h at 41C with anti-Dbl, anti ezrin (Santa Cruz Biotechnology) or antiXpress antibodies under constant rotation. Protein G-sepharose (30 ml) was added to each sample for 30 min. Immunoprecipitates were washed three times with lysis buffer, eluted in 30 ml of 1 Â Laemmli's buffer, subjected to 8% SDS-PAGE and transferred to PVDF membrane for immunoblotting.
Immunofluorescence NIH3T3 fibroblasts were plated onto glass coverslips, previously coated with 10 mg/ml fibronectin (Sigma), and transiently transfected with the different pCEFL-GST-Dbl constructs, pEF-1B erzrin f.l. or pEF-1B ezrin (Santa Cruz Biotechnology) DC alone or cotransfected with the various pCEFL-GST-Dbl constructs and pEF-1B ezrin f.l. or pEF-1B ezrin DC. After 36 h, cells were fixed with 4% paraformaldehyde in PBS for 30 min at 251C, and permeabilized with 0.1% Triton X-100 for 5 min. Alternatively, NIH3T3 cells, stable transfected with pCEFL-GST-Dbl, pEF-4B ezrin f.l., pEF-4B ezrin DC alone or cotransfected with pCEFL-GST-Dbl and pEF-4B ezrin f.l. or pEF-4B ezrin DC were plated onto glass coverslips, previously coated with 10 mg/ml fibronectin (Sigma) and allowed to adhere overnight before fixation and permeabilization. For triple immunofluorescence labeling, cells were incubated with anti-GST polyclonal antibodies (Molecular Probes, Eugene, OR, USA) for detection of the Dbl protein, followed by FITC-conjugated goat anti-rabbit IgG (Cappel, Organon Teknika Corp.) and with anti-His monoclonal antibody (Invitrogen) for detection of the ezrin protein, followed by Alexa Fluor 350-conjugated goat anti-mouse IgG (Molecular Probes, Eugene, OR, USA). Filamentous actin was visualized by incubating the cells with TRITClabeled phalloidin (Sigma) in PBS for 30 min at 251C. Focal adhesions were visualized by incubating the cells with antipaxillin monoclonal antibodies (Transduction Laboratories), followed by goat anti-mouse IgG-Texas red (Jackson Immunoresearch Laboratories, West Grove, PA, USA). Fluorescence signals were analysed by recording stained images using a cooled CCD color digital camera SPOT-2 (Diagnostic Instruments Incorporated, MI, USA) and FISH 2000/H1 software (Delta Sistemi, Roma, Italy).
